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Aims: Intensive lifestyle, dietary interventions and patient education have been recommended as 
key milestones in to facilitate the management of Diabetes and contain the growing incidence. We 
performed a systematic review and meta-analysis to assess the health benefits of medical nutrition 
therapy among patients with diabetes. Design: A systematic search was performed in 
MEDLINE/PubMed, SCOPUS, and Cochrane library from onset up to February 2019 to identify 
trials investigating the health effect of Medical nutrition (MNT) in patients with diabetes. Random-
effects models were used to calculate the effect sizes as weighted mean difference (WMD) and 
95% confidence intervals (CI). Results: Eleven studies containing 1227 participants were included 
in the meta-analysis. Pooled results showed a significant reduction in Fasting blood sugar (FBS) 
(WMD= −8.85 mg/dl, 95% CI: −14.41, −3.28), HbA1c (WMD: −0.43%, 95% CI: −0.69, −0.17), ] 
weight (WMD: −1.54 kg, 95% CI: −2.44, −0.64), Body mass index (BMI) (WMD: −0.34 Kg/m2, 
95% CI: −0.52,−0.17),waist circumference (WMD:−2.16 cm, 95% CI:−4.09,−0.23), cholesterol 
(WMD  −4.06 mg/dl, 95% CI: −7.31, −0.81), Systolic blood pressure (SBP) (WMD:  7.90mmHg, 
95% CI: −13.03,−2.77). Results of meta-regression analysis based on age of participants and 
duration of intervention were not significant.  
 
1. Introduction  
 The global prevalence of diabetes mellitus, defined as fasting  blood glucose equal to or higher 
than 7mmol/L, among adults  over 18 years of age has risen from 4.7% in 1980 to 8.5% in  
2014 (90–95% of which is Type 1I). Diabetes has been directly  linked to 1.6 million deaths 
globally. High blood glucose alone  was the cause of another 2.2 million deaths in 2015, and 
is an  established risk factor for coronary heart disease, ischaemic  stroke, and other vascular 
diseases [1–3]. Higher health care  use, economic burden and associated societal costs have 
been  reported among people with diabetes when compared to their  normal counterparts [4]. 
In the US, approximately 20% of the  nation’s health resource is spent treating peoplewith 
diabetes  [5]. In the UK, diabetes management accounts for around 10%  of the National Health 
Service budget and is projected to rise  to around 17% by 2035 [6].  Medical nutrition therapy 
have been recommended as  milestones in the management of type 2 diabetes. There is  
evidence supporting the effectiveness of patient education  and adherence to self management 
strategies on health out  comes [7,8]. National recommendations suggest promoting  the role 
of diabetes educators alongside treating physicians  to improve the coordination of care and 
facilitate better  outcomes in diabetes management [9,10]. Currently, studies evaluating the 
role of multidisciplinary diabetes care teams   that include physicians, nurses, pharmacists, and 
(or) dieti-   tians, have shown better patient outcomes such as reduction   in weight, BMI, and 
fasting blood sugars compared to usual   care [8,11–14]. However, many of these studies were 
poorly   designed. Methodological flaws such as measurement bias,   small sample size, lack 
of generalizability, short interven-   tion and follow-up periods were some of the issues 
identified   [11,15 17]. There is evidence to suggest that engaging other   skilled health 
professionals such as dietitians in primary care   improves patient outcomes [12]. Dietitians, 
both quality care   providers and educators have an important role to play within   
multidisciplinary diabetes care teams. The Diabetes Preven-   tion Program (DPP) provides 
clear indications for integrating   dietitians into lifestyle management to help patients change   
their eating and exercise behaviours and prevent diabetic   complications [18].   Nutritional 
therapy is one of the key components of pre-   vention and management strategies for Type 1 
and II diabetes   mellitus. A number of studies have also demonstrated sus-   tained 
improvements in HbA1c at 12 months [13,14]. These   effects were sustained for longer periods 
when a registered   dietitian provided follow-up visits ranging from quarterly   to monthly 
sessions [13,14]. Ongoing medical counselling   in nutritional management by a trained 
dietitian has been   shown to lead to better long-term metabolic control [19]. In   a clinical trial 
evaluating a 24-month intervention, weight  (−0.7 vs. + 2.1 kg), BMI (+0.3 vs. + 0.7 kg/m2), 
waist circum  ference (–1.3 vs. + 2.4 cm) and overall energy intake (−548  vs. −74 kcal/day) 
significantly differed between groups, with  nutritional therapy demonstrating greater 
improvement com  pared to the control group [20]. Another study by Bhopal,  reported 
significant weight loss in intervention group, vs  weight gain in control group following 
nutritional therapy [21].  Furthermore, Mohammadi and colleagues reported improve  ment in 
anthropometric measures, fasting blood sugar, 2-h  postprandial blood sugar, serum total 
cholesterol, serum ala  nine transaminase and increased circulating following diet  therapy [22].  
However, despite a substantial number of independent  studies reporting positive, and 
sustained, outcomes following  nutritional therapy, there is no consensus on its’ overarch  ing 
effect. Given the clinical importance of such nutritional  management in clinical practice and 
poor uptake of current  guideline recommendations.We sought to conduct a system  atic 
reviewandmeta-analysis of the health benefits ofmedical  nutrition therapy among patients with 
diabetes.  
 
2. Methods  
 This systematic review and meta-analysis was conducted  using recommendations outlined by 
the Preferred Reporting  Items of Systematic Reviews and Meta-Analysis statement  guidelines 
[23].   
2.1. Search strategy  A systematic search was conducted by combining med  ical subject 
headings (MeSH) and non MeSH terms in  PubMed/MEDLINE, Cochrane and SCOPUS with 
no language  or date restrictions. Databases were searched from inception  to February 2019 
(Supplemental Table1). To avoid missing any  relevant studies, reference lists of eligible 
studies and related  reviews were searched manually.   
2.2. Eligibility criteria  We included studies that met the following inclusion criteria:  All 
studies that evaluated the effect of Medical Nutrition  Therapy on diabetes patients were 
included in this meta  analysis. We defined medical nutrition therapy as nutritional  
consultation provided by a registered dietitian. We included  studies that met the following 
inclusion criteria: (1) studies,  irrespective of design that had control groups receiving usual  
care; (2) studies that evaluated the effectiveness of prescribing  Medical Nutrition Therapy by 
a Registered Dietitians; and (3)  reported sufficient information onmetabolic variables both in  
control and intervention groups. Prospective studies without  a suitable control group were 
excluded. We excluded studies  that did not report outcomemeasures (or changes in outcome  
measures) at baseline to the end of intervention or follow-up.  
2.3. Data extraction and quality assessment   Two independent researchers (H.K.V and J.R) 
screened and   extracted relevant data for all studies identified by the search   strategy. 
Discrepancies were resolved by consensus agree-   ment. When, consensus was not achieved, 
a senior author   (S.J.M.R.) involved in the study helped to resolve disagree-   ments. We 
extracted data on the following items from each   study: name of the first author, year of 
publication, type of   study population, number of participants in the interven-   tion and control 
groups, gender, participants mean age, study   location, study design, intervention components, 
intervention   duration, and type of diabetes. For the results, we extracted   information on the 
anthropometric, nutritional and biochem-   ical variables. Means and standard deviations of 
metabolic   variables at baseline, end of study and/or changes between   baseline and period of 
intervention delivery). When this data   was unavailable, we emailed the corresponding author 
to   obtain information missing in the published study report.    
2.4. Quality assessment of studies   We evaluated the quality of included trials using the 
Cochrane   quality assessment tool which comprises of the following   domains: random 
sequence generation, allocation conceal-   ment, blinding of participants and personnel, 
blinding of   outcome assessment, incomplete outcome data, selective   reporting and other 
probable sources of biases. To assess the   quality of studies, each study was assigned a label 
(yes, no or   unclear). This information was used to classify the study as   having a low risk, 
high risk or unknown risk of bias, respec-   tively [24]. Studies were judged to be of high risk 
of bias when   the randomization, allocation concealment and blinding was   not reported or 
not performed. Studies were judged to be of   low risk of bias when all critical items or more 
items on the   assessment domains were reported [24].    
2.5. Quantitative data synthesis   Mean change and standard deviation (SD) of the outcome   
measures were used to estimate the overall effect size. If   the SD of the mean difference was 
not reported in the   studies, we derived this value using the following formula:   SD change 
=square root [(SD baseline 2 +SD final 2) – (2×r×SD   baseline ×SD final)] [25]. The random-
effects model (using Der-   Simonian Laird method) was used to estimate the weighted   mean 
difference (WMD) and corresponding 95% confidence   intervals (95% CI). We carried out 
predefined subgroup analy-   sis for region (location of study) to detect potential sources of   
heterogeneity among the studies. Meta-regression was used   to determine the effect of duration 
of intervention and par-   ticipant age on intervention outcomes. Publication bias was   
evaluated by means of visual assessment of funnel plots and   Egger’s tests [26]. When 
publication bias was detected, it was   re-evaluated using the ‘trim and fill’ approach [27]. 
Sensitiv-   ity analysis was performed to investigate the effect of each   study on overall 
analysis. All statistical analyses were exe-   cuted using Stata software (Stata Corp. College 
Station, Texas,   USA).    
3. Results  
 We retrieved 266 studies using our search strategy after remov  ing duplicates papers 
(Supplemental Figure 1). At title and  abstract screening, 241 papers were removed using the 
study  selection criteria and 25 articles were retained for full text  eligibility assessment. Eleven 
articles [28–38] met the review  inclusion criteria. Fourteen studies were excluded for the fol  
lowing reasons: (1) outcome data was presented in unsuitable  format and attempts to obtain 
complete data was unsuccess  ful (n= 7), (2) did not include control group comparisons (n= 4),  
and (3) intervention was designed without including a nutri  tionist (n= 3).   
3.1. Study characteristics  Table 1 presents the characteristics of included studies. Stud  
ieswere conducted in theUS [28,31–33,36], China [30], Iran [29],  Canada [34], Taiwan [35], 
Italy [37], and Finland [38]. Studies  were published between 1999–2018 and duration of 
interven  tion was between 10 104 weeks. Mean age of participants was  54 (45–66) years. Ten 
studies were evaluated among patients  with diabetes [28 30,32–38] and one conducted on pre-
patients  with diabetes [31]. Routine care was the common interven  tions evaluated among the 
control groups. Table 2 shows the  risk of bias assessment of studies included in this review. 
One  study in selection bias (Randomsequence generation) [35] and  two study in selection bias 
(allocation concealment) [16,38]  had low risk of bias.   
3.2. Interventions  Most intervention groups in studies included this review  received 
recommendations for physical activity and individ  ualized nutrition counselling to promote 
health and behavior  change by a registered dietitian.   
3.3. Results of meta-analysis  Eight studies providing a total of 612 participants in inter  
vention group and 588 participants in control group with  data reported on levels of Fasting 
blood sugar as an out  come variable [29–32,34,35,37,38]. Results combined using  random 
effects model showed a significant reduction in FBS  levels following medical nutrition 
therapy (MNT) interven  tion (Weighted mean difference(WMD): −8.85mg/dl, 95% CI:  
−14.41, −3.28) (Fig. 1). Significant heterogeneity was identified  among studies (p = 0.001, I2 
= 76%).  We combined results from eight studies [30–37] that  reported HBA1C as an outcome 
measure using a random  effects model. This provided a total of 1032 participants  
(intervention= 522 and control = 510). The results demon  strated that MNT intervention 
significantly reduced HBA1C  levels (WMD: −0.43%, 95% CI: −0.69, −0.17) in the 
intervention  group compared to the control group (routine care). How  ever, we identified 
significant heterogeneity among studies  (p = 0.004, I2 = 94%).  In six studies (seven arms) that 
reported weight as an  outcome variable, there was a total of 556 participants in intervention 
group and 534 participants in control group  [28–30,32,34,38]. Pooled results using random 
effects model  showed a significant reduction in weight in the MNT group  compared with the 
control group (WMD: −1.54 kg, 95% CI:  −2.44, −0.64). There was significant heterogeneity 
among  included studies (p = 0.001, I2 = 77%).  Six studies (seven arms) containing 240 
participants in  MNT group and 242 participants in control group reported BMI  as an outcome 
variable [29,30,33–35,37]. Pooled results showed  that BMI was reduced in the intervention 
group compared  with the control group (WMD: −0.34 Kg/m2, 95% CI: −0.52,  −0.17). There 
was no significant heterogeneity among studies  (p = 0.39, I2 = 4.5%).  Five studies reported 
waist circumstance as an outcome  measure [29,32,34,37,38]. In comparison with the control  
group, the MNT group showed a significant reduction in  waist circumstance (WMD: −2.16 
cm, 95% CI: −4.09, −0.23).  There was significant heterogeneity among included studies  (p = 
0.001, I2 = 93).  Eight studies containing a total of 748 participants (382  participants in 
intervention group and 366 participants in con  trol group) reported cholesterol levels as an 
outcomemeasure  [29–31,34–38]. We combined results using a random effects  model and 
demonstrated a significant reduction in cholesterol  levels followingMNT intervention (WMD: 
−4.06mg/dl, 95% CI:  −7.31, −0.81) (Fig. 1). There was no significant heterogeneity  between 
studies (p = 0.29, I2 = 16). For TG, the combined effect size using a random effects   modelwas 
-8.82 mg/dl (95% CI  20.10, 2.45) [30,31,34,35,37,38].   We identified significant 
heterogeneity between studies   (p = 0.03, I2 = 57%).   Four studies reported LDL as outcome 
variables   [29,31,34,35]. MNT group showed significant reduction in   LDL levels (WMD: 
−4.43 mg/dl, 95% CI: −13.66, 4.80) compared   with the control group. Therewas no significant 
heterogeneity   between studies (p = 0.12, I2 = 47%).   Overall, results from six studies 
[29,31,34,35,37,38] con-   ducted among 605 participants were combined using a   random-
effects model. The results showed that MNT did not   have any significant effect on HDL levels 
(WMD: −0.40 mg/dl,   95% CI: −3.20, 2.40). Significant heterogeneity was found   among 
studies (p = 0.001, I2 = 89).   Seven studies providing 694 participants reported SBP as   an 
outcome variable [29,30,33–35,37,38]. Results pooled using   random effects model 
demonstrated a significant reduction   in the MNT group compared with the control group 
(WMD:   −7.90mmHg, 95% CI: −13.03, −2.77). There was significant   heterogeneity among 
studies (p = 0.001, I2 = 93). Furthermore,   using a random-effects model we combined results 
of stud-   ies evaluating the impact of nutritional therapy on DBP   [29,30,33–35,37,38]. The 
results indicated a significant reduc-   tion in DBP levels (WMD:−2.60mmHg,95% CI:−4.27, 
0.94) with   significant heterogeneity among included studies (p = 0.001,   I2 = 72).   
3.4. Subgroup analysis and meta-regression  Table 3 shows results of the subgroup 
analyses. Studies were  stratified based on continents (North American and Eurasian  
continents). Subgroup analyses showed that Medical Nutri  tional therapy had significantly 
higher effects on FBS, HBA1C,  and weight reduction among participant within Eurasian con  
tinent compared with their North American counterparts.We  did not consider subgroup 
analysis for BMI, Cholesterol, and  LDL because these outcomes showed negligible 
heterogeneity.  Also, we did not consider subgroup analysis for waist circum  stance, TG, HDL, 
SBP, and DBP because there were insufficient  studies within these subgroups.  We performed 
meta regression analyses on FBS, HBA1C,  weight, BMI, Cholesterol, LDL, waist 
circumstance, TG, HDL,  SBP, and DBP based on age of participants and duration of  
intervention (Supplemental Figs. 2 and 3) but there is no  significant relationship between 
changes in outcome and par  ticipants age or intervention duration.  3.5. Publication bias and 
sensitivity analysis  The Funnel plot (Supplemental Fig. 4), Egger’s and Begg’s  tests did not 
show any publication bias for FBS (p = 0.39,  p = 0.32), HBA1C (p = 0.09, p = 0.45), Weight 
(p = 0.13, p = 0.17),  BMI (p = 0.14, p = 0.29), waist circumstance (p = 0.05, p = 0.32),  TG (p 
= 0.17, p = 0.85), and HDL (p = 0.93, p = 0.85) (Supplemen  tal Fig. 4). There was a significant 
publication bias (Egger’s  and Begg’s tests) for cholesterol (p = 0.02, p = 0.13), LDL (p = 0.01,  
p = 0.04), SBP (p = 0.04, p = 0.65), and DBP (p = 0.02, p = 0.02). We  used ‘trim and fill’ 
method for adjusting publication bias but  did not detect potentially missing studies that could 
have  biased the results of this meta-analyses. Sensitivity analysis  did not show any significant 
differences beyond the limits of  95% CI between calculated SESs for MNT intervention 
studies  (Supplemental Fig. 5).  
 
4. Discussion  
This systematic review evaluated the effectiveness of medical   nutrition in developing the 
treatment plan for patients with   diabetes. We found evidence to support the effectiveness of   
medical nutrition therapy (MNT) on almost all anthropometric   and biochemical outcomes, 
expect high and low density lipo-   proteins. However, the clinical relevance of this differences   
remains unknown as most interventions involved multiple   components. Furthermore, the 
duration of the intervention   across included studies suggest thatmultiple encounters may   be 
required to observe desired changes. However, lifestyle   interventions such as MNT, which 
demonstrate small effect   may exert large impact at a population level.   Results of our sub-
group analysis showed higher improve-   ment in some biochemical parameters - FBS, HBA1C 
and   weight gain among participants in the Eurasian region   compared with their North 
American counterparts. This dif-   ferences in outcomes between participants from different   
continents might be due to genetic variations and differences   in lifestyle. Suggesting that 
health practitioners may need to   tailor their approach when managing different patient groups.   
Although, we did not observe differences in outcome with a   sub-group analysis after meta-
regression for age or duration of   intervention, thismay have been masked by the small number   
of studies evaluating long-term outcomes. Sub-group analysis   by intervention duration was 
limited by the nature of the data   retrieved from studies included in this review.    
4.1. Comparison with previous findings   A previous systematic review by Moller et al. [39] 
showed sim-   ilar results to our study. At short-term (6–12 months). The   authors [39] reported 
improvement in HbA1c 0.55 (95% CI:   0.02–1.1) BMI, 2.1-kg (95% CI: 1.2–2.9-kg) and LDL 
cholesterol   0.17-mmol/L (95% CI: 0.11–0.23-mmol/L) due to nutrition ther-   apy compared 
to dietary advice.However, the size and number   of studies included in that review, as well as 
the methodolog-   ical qualities of studies made it difficult to provide definite   conclusions 
about the effectiveness of nutrition therapy. Cur-   rent guidelines for managing diabetes 
recommend MNT for   patients with diabetes. In this study we found evidence to   support the 
multi-faceted impact of MNT shown by previ-   ous reports [40,41]. Also, there is evidence to 
recommend   the provision of MNT by qualified health care profession-   als (i.e. Dietitians) 
and incorporate tailored approaches to   yield sustainable outcomes. Medical nutrition therapy 
has also   been recommended by American guidelines, documenting   evidence of clinical 
benefits for physiological parameters and   disease management [42]. However, the evidence 
to support   the long-term provision of this therapy remains scarce and at   best uncertain [41]. 
Considering the resource intensive nature   of MNT, studies evaluating long term clinical 
benefits and   cost-effectiveness of MNT are needed to inform guidelines.    
4.2. Limitations   Although, the results of this review were generated using   evidence from a 
larger total sample size, there were some lim-   itations with the review process. The results of 
this review   are limited by inherent bias in the original studies used to  synthesis evidence on 
MNT. A number of studies included  in this review were heterogeneous used short-term 
follow-up  durations and varying assessment techniques. There was sig  nificant heterogeneity 
between most studies used to evaluate  these outcomes that remained even after sensitivity anal  
ysis. Most studies showed high or unclear risk of bias for  critical domains of randomization 
or allocation concealment.  This may have inflated the effect size observed, limiting the  
strength of the evidence and consequently, the recommenda  tions generated by this review.We 
performed a comprehensive  search process and assessments for publication bias, poorly or  
non-indexed papers could still have been missed that could  have influenced the results of our 
study. Also, we were limited  by the reporting characteristics nature of the studies included  in 
this review. We were unable to retrieve complete outcome  data despite attempts to contact 
corresponding authors.  Lifestyle interventions such as medical nutrition ther  apy are mostly 
delivered as part of a multi-component  management strategies. The synergistic effects from 
other  complimentary interventions, cultural and contextual fac  tors may have contributed to 
the weight of the effect sizes  observed. In this study, we did not adjust for known or  unknown 
mediating factors that could explain a significant  part of the intervention effect we observed. 
Therefore, we  advise caution when interpreting the results of this study as  mediating factors 
such as physical activity levels were not  adjusted for and most studies were evaluated at short-
term  follow-up. Future studies should explore the effectiveness of  medical nutrition using 
robust designs in a clearly defined pre  diabetic or diabetic patient group and use longer follow 
up  duration.  
5. Conclusions 
 This systematic review and meta-analysis found evidence to  support incorporating medical 
nutrition therapy as a cen  tral component of the management of diabetes mellitus.  
Improvements were observed in outcome measures of FBS,  HBA1C, weight, BMI, waist 
circumference, cholesterol, and  SBP. Sub-group analysis showed difference by continents, but  
no significant associations were found for the effect of age or  intervention duration. Future 
studies should explore the effect  of MNT as an early preventative intervention in pre-diabetic  
patient groups, evaluate long term maintenance effects and  self-management approaches 
among diabetic patient groups.  
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Supplemental Table 1. Search strategy. 
PubMed/MEDLINE Cochrane library  Scopus  
((("Clinical Trials as Topic"[Mesh] OR "Cross-Over 
Studies"[Mesh] OR "Double-Blind Method"[Mesh] OR 
"Single-Blind Method"[Mesh] OR "Random 
Allocation"[Mesh] OR RCT[Title/Abstract] OR 
"Intervention Studies"[Title/Abstract] OR 
"intervention"[Title/Abstract] OR "controlled 
trial"[Title/Abstract] OR "randomized"[Title/Abstract] 
OR "randomised"[Title/Abstract] OR 
"random"[Title/Abstract] OR "randomly"[Title/Abstract] 
OR "placebo"[Title/Abstract] OR 
"assignment"[Title/Abstract]) AND ("nutrition 
therapy"[Mesh] OR "nutrition therapy"[tiab] OR 
"nutrition counseling"[tiab] OR "nutrition 
intervention"[tiab] OR "nutrition monitoring"[tiab] OR 
"Medical Nutrition Therapy"[tiab] OR "nutritional 
service"[tiab] OR "nutritional services"[tiab] OR 
"nutrition services"[tiab] OR "nutrition service"[tiab] 
OR "Dietary service"[tiab] OR "Dietary services"[tiab] 
OR "food services"[tiab] OR "food service"[tiab] OR 
"Dietary Services"[Mesh] OR "clinical nutrition 
service"[tiab] OR "diet therapy"[tiab] OR "nutrition 
therapy"[tiab] OR "food therapy"[tiab] OR "Diet 
Therapy"[Mesh])) AND ("dietitian*"[tiab] OR 
"dietician*"[tiab] OR "nutritionist*"[tiab] OR 
"Nutritionists"[Mesh])) AND ("Diabetes 
Mellitus"[Mesh] OR "Diabetes Mellitus, Type 2"[Mesh] 
OR "Diabetes, Gestational"[Mesh] OR "Diabetes 
Insipidus"[Mesh] OR "Diabetes Complications"[Mesh] 
OR "Diabetes Mellitus, Type 1"[Mesh] OR "Diabetes 
Mellitus"[tiab] OR "Type 2 Diabetes Mellitus"[tiab] OR 
"Gestational Diabetes"[tiab] OR "Diabetes 
Insipidus"[tiab] OR "Diabetes Complications"[tiab] OR 
"Type 1 Diabetes Mellitus"[tiab] OR ("Diabetes 
Mellitus"[Mesh] OR Diabetes[TIAB])) 





OR "Medical Nutrition 
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"nutritional services" OR 
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"Dietary Services" OR 
"clinical nutrition 
service" OR "diet 
therapy" OR "nutrition 
therapy" OR "food 
therapy") AND (dietitian 
OR dietician OR 
nutritionist) AND 
("Diabetes Mellitus" OR 
Diabetes OR "Diabetes 
Insipidus" OR "Diabetes 
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OR diabetic OR diabete) 
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"nutrition counseling" ) OR TITLE-ABS-KEY ( "nutrition intervention" ) 
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) OR TITLE-ABS-KEY ( "nutritional services" ) OR TITLE-ABS-KEY ( 
"nutrition services" ) OR TITLE-ABS-KEY ( "nutrition service" ) OR 
TITLE-ABS-KEY ( "Dietary service" ) OR TITLE-ABS-KEY ( "Dietary 
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( "food service" ) OR TITLE-ABS-KEY ( "Dietary Services" ) OR TITLE-
ABS-KEY ( "clinical nutrition service" ) OR TITLE-ABS-KEY ( "diet 
therapy" ) OR TITLE-ABS-KEY ( "nutrition therapy" ) OR TITLE-ABS-
KEY ( "food therapy" ) OR TITLE-ABS-KEY ( "Diet Therapy" ) ) ) AND ( 
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Supplemental Fig 2. Meta regression based on age on: 
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Supplemental Fig 3. Meta regression based on follow-up duration: 
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Supplemental Figures 4: Funnel plot to assess publication bias.  
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Supplemental Fig 5. Sensitivity analysis on: 
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